212 related articles for article (PubMed ID: 27189625)
1. Icatibant Compared to Steroids and Antihistamines for ACE-Inhibitor-Induced Angioedema.
Botnaru T; Robert A; Mottillo S
CJEM; 2017 Mar; 19(2):159-162. PubMed ID: 27189625
[TBL] [Abstract][Full Text] [Related]
2. [Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor].
Fast S; Henningsen E; Bygum A
Ugeskr Laeger; 2011 Oct; 173(41):2574-5. PubMed ID: 21985837
[TBL] [Abstract][Full Text] [Related]
3. Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema.
Fok JS; Katelaris CH; Brown AF; Smith WB
Intern Med J; 2015 Aug; 45(8):821-7. PubMed ID: 25944565
[TBL] [Abstract][Full Text] [Related]
4. Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema.
Straka BT; Ramirez CE; Byrd JB; Stone E; Woodard-Grice A; Nian H; Yu C; Banerji A; Brown NJ
J Allergy Clin Immunol; 2017 Jul; 140(1):242-248.e2. PubMed ID: 27913306
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of icatibant in ACE-inhibitor-induced angioedema.
Baş M; Greve J; Stelter K; Havel M; Strassen U; Rotter N; Veit J; Schossow B; Hapfelmeier A; Kehl V; Kojda G; Hoffmann TK
N Engl J Med; 2015 Jan; 372(5):418-25. PubMed ID: 25629740
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Life-Threatening ACE-Inhibitor-Induced Angioedema.
Hirschy R; Shah T; Davis T; Rech MA
Adv Emerg Nurs J; 2018; 40(4):267-277. PubMed ID: 30365440
[TBL] [Abstract][Full Text] [Related]
7. Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors.
Gallitelli M; Alzetta M
Am J Emerg Med; 2012 Oct; 30(8):1664.e1-2. PubMed ID: 22100478
[TBL] [Abstract][Full Text] [Related]
8. Treatment of ACEI-related angioedema with icatibant: a case series.
Bova M; Guilarte M; Sala-Cunill A; Borrelli P; Rizzelli GM; Zanichelli A
Intern Emerg Med; 2015 Apr; 10(3):345-50. PubMed ID: 25666515
[TBL] [Abstract][Full Text] [Related]
9. Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema.
Sinert R; Levy P; Bernstein JA; Body R; Sivilotti MLA; Moellman J; Schranz J; Baptista J; Kimura A; Nothaft W;
J Allergy Clin Immunol Pract; 2017; 5(5):1402-1409.e3. PubMed ID: 28552382
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.
Bas M; Greve J; Stelter K; Bier H; Stark T; Hoffmann TK; Kojda G
Ann Emerg Med; 2010 Sep; 56(3):278-82. PubMed ID: 20447725
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review.
Lawlor CM; Ananth A; Barton BM; Flowers TC; McCoul ED
Otolaryngol Head Neck Surg; 2018 Feb; 158(2):232-239. PubMed ID: 29112487
[TBL] [Abstract][Full Text] [Related]
12. [ACE-inhibitor induced angioedema].
Bas M; Hoffmann TK; Kojda G; Bier H
Laryngorhinootologie; 2007 Nov; 86(11):804-8, quiz 809-13. PubMed ID: 17966084
[TBL] [Abstract][Full Text] [Related]
13. Icatibant and ACE inhibitor angioedema.
Illing EJ; Kelly S; Hobson JC; Charters S
BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22936825
[TBL] [Abstract][Full Text] [Related]
14. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.
Bartal C; Zeldetz V; Stavi V; Barski L
Am J Emerg Med; 2015 Mar; 33(3):479.e1-3. PubMed ID: 25241359
[TBL] [Abstract][Full Text] [Related]
15. [Upper airway obstruction caused by ACE inhibitor-induced angioedema].
Kongstad T; Islander G
Lakartidningen; 2012 Apr 4-10; 109(14-15):758-61. PubMed ID: 22611881
[No Abstract] [Full Text] [Related]
16. Bradykinin-receptor antagonist icatibant: possible treatment for ACE inhibitor-related angio-oedema.
Manders K; van Deuren M; Hoedemaekers C; Simon A
Neth J Med; 2012 Oct; 70(8):386-7. PubMed ID: 23065991
[No Abstract] [Full Text] [Related]
17. Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: A meta-analysis of randomized controlled trials.
Jeon J; Lee YJ; Lee SY
J Clin Pharm Ther; 2019 Oct; 44(5):685-692. PubMed ID: 31290163
[TBL] [Abstract][Full Text] [Related]
18. Commentary regarding: A randomized trial of icatibant in ACE-inhibitor-induced angioedema.
Yancey KB
Dermatol Ther; 2015; 28(5):331. PubMed ID: 25818322
[No Abstract] [Full Text] [Related]
19. Treatment with icatibant in the management of drug induced angioedema.
Bertazzoni G; Bresciani E; Cipollone L; Fante E; Galandrini R
Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):149-53. PubMed ID: 25635988
[TBL] [Abstract][Full Text] [Related]
20. Angioedema induced by angiotensin converting enzyme inhibitors, potentiated by m-TOR inhibitors: successful treatment with icatibant.
Charmillon A; Deibener J; Kaminsky P; Louis G
Intensive Care Med; 2014 Jun; 40(6):893-4. PubMed ID: 24737261
[No Abstract] [Full Text] [Related]
[Next] [New Search]
